Effect of losartan and spironolactone on left ventricular mass and heart sympathetic activity in prehypertensive obese subjects: a 16-week randomized trial-Reference-Cited by-同舟云学术

Effect of losartan and spironolactone on left ventricular mass and heart sympathetic activity in prehypertensive obese subjects: a 16-week randomized trial

Published:2005-01-27 Issue:4 Volume:19 Page:277-283
ISSN:0950-9240
Container-title:Journal of Human Hypertension
language:en
Short-container-title:J Hum Hypertens

Author:

Amador N,Encarnación J J,Guízar J M,Rodríguez L,López M

Publisher

Springer Science and Business Media LLC

Subject

Internal Medicine

Link

http://www.nature.com/articles/1001816.pdf

Reference34 articles.

1. Rumantir MS, Vaz M . Neural mechanisms in human obesity-related hypertension. J Hypertens 1999; 17: 1125–1133.

2. Karason K, Molgaard H, Wikstrand J, Sjostryom L . Heart rate variability in obesity and the effect of weight loss. Am J Cardiol 1999; 83: 1242–1247.

3. Amador N et al. Leptin and heart sympathetic activity in normotensive obese and non obese subjects. Ital Heart J 2004; 5: 29–35.

4. Levy D et al. Prognostic implications of echocardiographic determined left ventricular mass in the Framingham heart study. N Engl J Med 1990; 322: 1561–1566.

5. Amador N et al. Relationship between left ventricular mass and heart sympathetic activity in male obese subjects. Arch Med Res 2004; 35: 54–58.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of weight loss on blood pressure changes in overweight patients: A systematic review and meta‐analysis;The Journal of Clinical Hypertension;2023-05

2. The Role of Angiotensin Receptor Blockers in the Personalized Management of Diabetic Neuropathy;Journal of Personalized Medicine;2022-07-30

3. Prehypertension: Underlying pathology and therapeutic options;World Journal of Cardiology;2014

4. Hypertension and Cardiac Arrhythmias;Current Pharmaceutical Design;2007-09-01

5. Hypertensive Heart Disease and the Role of Aldosterone Antagonists;Current Hypertension Reviews;2007-05-01